High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study

OBJECTIVE: Pharmacological treatment of non-alcoholic fatty liver disease (NAFLD) is still evolving. Probiotics could be a promising treatment option, but their effectiveness needs to be established. The present study aimed to evaluate the efficacy of a high potency multistrain probiotic in adult pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Gastroenterol
Autors principals: Duseja, Ajay, Acharya, Subrat K, Mehta, Manu, Chhabra, Shruti, Rana, Satyavati, Das, Ashim, Dattagupta, Siddhartha, Dhiman, Radha K, Chawla, Yogesh K
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Hepatology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688701/
https://ncbi.nlm.nih.gov/pubmed/31423319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2019-000315
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars